Molnupiravir – what you need to know
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at… read more.
Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at… read more.
At the opening session of the 2021 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting awards for excellence in pharmacy practice leadership were made to two ASHP… read more.
Research from pharmacologists at the University of Sydney provides new insights into how cannabis extracts may work to treat epilepsy. The study for the first time reports that… read more.
Medicines approved by the European Medicines Agency (EMA) to treat one illness could be repurposed by academics and non-governmental organisations as therapies for other illnesses, as part of… read more.
Pharmacists and pharmacy technicians are set to benefit from a further investment of up to £15.9m over the next four years. This investment, announced by Health Education England… read more.
Inviting your MP to spend a day shadowing your work is a good way to raise awareness of the critical work that pharmacists undertake in the healthcare system,… read more.
In response to Sajid Javid’s statement that he would give pharmacists the right to prescribe to give doctors more time with patients, Jonathan Ashworth immediately tweeted that pharmacists… read more.
Patients using take-home technology following non-elective surgery resulted in significantly greater detection and correction of drug errors, and reduction in patients’ pain, says a national study led by… read more.
A robust business case can be made for the VTE service and the coronavirus pandemic has further demonstrated the value of the service, according to Mr Kieron Power;… read more.
Ministers are announcing action to prevent medicines being prescribed unnecessarily, following a new review led by Dr Keith Ridge CBE, Chief Pharmaceutical Officer for England. The review of… read more.
Patient pathways, independent prescribing by pharmacists and education of junior doctors all contribute to the effective operation of the VTE service, according to Mr Kieron Power; Lead Pharmacist… read more.
Recurrence of venous thrombo-embolism (VTE) may be more common than people think and 30% of people develop post thrombotic syndrome, according to Mr Kieron Power; Lead Pharmacist –… read more.